November 25, 2021
NEW YORK (Reuters Health) – For patients with metastatic melanoma, triplet therapy with atezolizumab and vemurafenib plus cobimetinib provides significant survival benefits over vemurafenib plus cobimetinib […]
November 25, 2021
(Reuters Health) – Women with newly diagnosed ovarian cancer and a BRCA mutation see sustained benefits in progression free survival rates after two years of maintenance […]
November 24, 2021
The San Antonio Breast Cancer Symposium (SABCS) 2021 will “be a great meeting,” according to Carlos Arteaga, MD, director of Simmons Comprehensive Cancer Center at UT […]
November 24, 2021
The decisions have been gut-wrenching. Should she try another round of chemotherapy, even though she barely tolerated the last one? Should she continue eating, although it’s […]
November 24, 2021
For the first time, a product is available specifically for use in patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors. The product […]
November 23, 2021
People with cancer who do not develop antibodies against SARS-CoV-2 after a standard vaccination series may do so after receiving a COVID-19 booster, according to a […]
November 23, 2021
A cancer immunologist who as of 2017 was “the most highly cited immunologist in Australia” has “seriously breached Codes relating to responsible research conduct,” according to […]
November 22, 2021
A new systematic review revealed that people living with certain cancers as well as those in remission face a significantly higher risk for stroke than people […]
November 22, 2021
Key Takeaways Venetoclax treatment combinations show benefit as first-line and follow-up therapy for adults with acute myeloid leukemia (AML), as well as patients who relapse after […]